Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
ABH HealthcareNSE:ABH +9.92%15 Return-on-Tangible-Asset is 12.61% as of Mar. 2025, which is 221% above its 10-year median of 3.93. GuruFocus rates NSE:ABH with a GF Score™ of 15/100. The stock has 2 warning signs investors should review. Among 687 Healthcare Providers & Services companies, ABH Healthcare ranks better than 72.78% on this metric.
Return-on-Tangible-Asset is calculated as Net Income divided by its average total tangible assets. Total tangible assets equals to Total Assets minus Intangible Assets. ABH Healthcare's annualizedNet Income for the quarter that ended in Mar. 2025 was ₹ Mil. ABH Healthcare's average total tangible assets for the quarter that ended in Mar. 2025 was ₹ Mil. Therefore, ABH Healthcare's annualized Return-on-Tangible-Asset for the quarter that ended in Mar. 2025 was 12.61%.
The historical rank and industry rank for ABH Healthcare's Return-on-Tangible-Asset or its related term are showing as below:
NSE:ABH'
s Return-on-Tangible-Asset Range Over the Past 10 Years
Min: 0.32 Med: 3.93 Max: 9.28
Current: 7.58
During the past 4 years, ABH Healthcare's highest Return-on-Tangible-Asset was 9.28%. The lowest was 0.32%. And the median was 3.93%.
NSE:ABH's Return-on-Tangible-Asset is ranked better than 72.78% of 687
companies
in the Healthcare Providers & Services industry
Industry Median: 2.59
vs NSE:ABH: 7.58
Return-on-Tangible-Asset measures the rate of return on the average total tangible assets (total assets minus intangible assets). Tangible means physical in nature. Intangible Assets are assets that are not physical in nature, and typically "derive their value from legal or intellectual rights." Return-on-Tangible-Asset measures a firm's efficiency at generating profits from its tangible assets. It shows how well a company uses what it has to generate earnings. Return-on-Tangible-Assets can vary drastically across industries. Therefore, Return-on-Tangible-Asset should not be used to compare companies in different industries.
Be Aware
Like ROE and ROA, Return-on-Tangible-Asset is calculated with only 12 months data. Fluctuations in the companys earnings or business cycles can affect the ratio drastically. It is important to look at the ratio from a long term perspective. Return-on-Tangible-Asset can be affected by events such as stock buyback or issuance, and by a companys tax rate and its interest payment. Return-on-Tangible-Asset may not reflect the true earning power of the assets. A more accurate measurement is ROC % (ROC).
Many analysts argue the higher return the better. Buffett states that really high Return-on-Tangible-Asset may indicate vulnerability in the durability of the competitive advantage.
ABH Healthcare Return-on-Tangible-Asset Related Terms
ABH Healthcare Return-on-Tangible-Asset Historical Data
* Premium members only.
The historical data trend for ABH Healthcare's Return-on-Tangible-Asset can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
ABH Healthcare Return-on-Tangible-Asset Chart
ABH Healthcare Annual Data
Trend
Mar22
Mar23
Mar24
Mar25
Return-on-Tangible-Asset
0.33
2.41
5.30
9.21
ABH Healthcare Quarterly Data
Mar25
Return-on-Tangible-Asset
12.61
NSE:ABH vs : Return-on-Tangible-Asset Comparison
For the Medical Care Facilities subindustry, ABH Healthcare's Return-on-Tangible-Asset, along with its competitors' market caps and Return-on-Tangible-Asset data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
ABH Healthcare Return-on-Tangible-Asset vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, ABH Healthcare's Return-on-Tangible-Asset distribution charts can be found below:
* The bar in red indicates where ABH Healthcare's Return-on-Tangible-Asset falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
In the calculation of annual Return-on-Tangible-Asset, the net income of the last fiscal year and the average total tangible assets over the fiscal year are used. In calculating the quarterly data,
the Net Income data used here is four times the quarterly (Mar. 2025) net income data.
What does a Return-on-Tangible-Asset of 12.61% mean?
ABH Healthcare (NSE:ABH) has a Return-on-Tangible-Asset of 12.61% as of Mar. 2025. Return on tangible assets is the ratio of current-period net income to average two-period tangible assets. View historical data on ABH Healthcare and its competitors. This is 221% above median its historical median of 3.93. Over the past decade, ABH Healthcare's Return-on-Tangible-Asset has ranged from 0.32 to 9.28. According to the industry distribution chart, ABH Healthcare ranks #187 out of 687 companies in the Healthcare Providers & Services industry, placing it in the top 27.2%.
Is ABH Healthcare's Return-on-Tangible-Asset too high?
ABH Healthcare's current Return-on-Tangible-Asset of 12.61% is 221% above median its 10-year median of 3.93. Over the past 10 years, this metric has ranged from a low of 0.32 to a high of 9.28. The Healthcare Providers & Services industry median Return-on-Tangible-Asset is 2.59. ABH Healthcare's value of 12.61% is 386.9% above this industry median. Based on the distribution chart, ABH Healthcare ranks #187 out of 687 companies in the Healthcare Providers & Services industry, which is above the industry midpoint. Overall, ABH Healthcare has a GF Score™ of 15/100, reflecting its overall financial health beyond just this single metric.
How does ABH Healthcare's Return-on-Tangible-Asset compare to ?
According to the Healthcare Providers & Services industry distribution chart, ABH Healthcare ranks #187 out of 687 companies for Return-on-Tangible-Asset. This puts ABH Healthcare in the upper half of its industry. The industry median Return-on-Tangible-Asset is 2.59. ABH Healthcare's value of 12.61% is 386.9% above this benchmark. Historically, ABH Healthcare's own Return-on-Tangible-Asset has ranged from 0.32 to 9.28 over the past decade. While the company's 10-year median is 3.93 vs. the industry median of 2.59, ABH Healthcare has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Return-on-Tangible-Asset for a Healthcare Providers & Services company?
The median Return-on-Tangible-Asset among Healthcare Providers & Services companies is 2.59, based on 687 companies in the industry. Companies in the top quartile (top 25%) have a Return-on-Tangible-Asset significantly above this median, while those in the bottom quartile fall well below. However, Return-on-Tangible-Asset should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. ABH Healthcare's current Return-on-Tangible-Asset of 12.61% is 386.9% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Return-on-Tangible-Asset mean?
A high Return-on-Tangible-Asset can signal that a stock is expensive relative to its fundamentals. Return on tangible assets is the ratio of current-period net income to average two-period tangible assets. View historical data on ABH Healthcare and its competitors. For the Healthcare Providers & Services industry, the median Return-on-Tangible-Asset is 2.59 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. ABH Healthcare's current Return-on-Tangible-Asset is 12.61%, which is 221% above median its own 10-year median of 3.93. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is ABH Healthcare stock overvalued right now?
ABH Healthcare (NSE:ABH) has a current Return-on-Tangible-Asset of 12.61%. The current Return-on-Tangible-Asset is 12.61%, which is 221% above median its 10-year median of 3.93 and 386.9% above the Healthcare Providers & Services industry median of 2.59. ABH Healthcare's overall GF Score™ is 15/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Return-on-Tangible-Asset calculated?
Return-on-Tangible-Asset is calculated from a company's financial statements. For ABH Healthcare (NSE:ABH), the current Return-on-Tangible-Asset is 12.61% as of Mar. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
ABH Healthcare Ltd is engaged in the business of establishing, maintaining, and assisting healthcare services in India, in the form of Super Speciality Hospitals and allied services such as Laboratories & Diagnostic Centres, Blood Bank and other related services. Its medical services cover specialties such as cardiology, neurology, gastroenterology, urology, pulmonology, nephrology, obstetrics and gynecology, critical care, orthopedics, general and laparoscopic surgery, dentistry, physiotherapy, dermatology, and radiology. The company derives the majority of inpatient revenue from its internal medicine, cardiology, neurosurgery, and orthopedics / joint replacement/trauma services.
15GF Score
Get the complete analysis for NSE:ABH
Return-on-Tangible-Asset is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
NSE:ABH has been successfully added to your 
